To 42.62%
SMS Pharmaceuticals announced that it has further invested Rs 3.81 crore by subscribing to 169,665 equity shares of Rs 10 each at a price of Rs 225 per share of VKT Pharma on 23 May 2017. With this acquisition, the Company's stake in VKT Pharma has increased to 42.62%.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content